- Home
- GYRE vs SBH Comparison
GYRE vs SBH Comparison
Compare GYRE & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- SBH
- Stock Information
- Founded
- GYRE 2002
- SBH 1964
- Country
- GYRE United States
- SBH United States
- Employees
- GYRE N/A
- SBH N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- SBH Other Specialty Stores
- Sector
- GYRE Health Care
- SBH Consumer Discretionary
- Exchange
- GYRE Nasdaq
- SBH Nasdaq
- Market Cap
- GYRE 990.4M
- SBH 940.7M
- IPO Year
- GYRE N/A
- SBH 2006
- Fundamental
- Price
- GYRE $7.72
- SBH $9.03
- Analyst Decision
- GYRE
- SBH Buy
- Analyst Count
- GYRE 0
- SBH 6
- Target Price
- GYRE N/A
- SBH $12.70
- AVG Volume (30 Days)
- GYRE 221.1K
- SBH 2.3M
- Earning Date
- GYRE 03-17-2025
- SBH 05-08-2025
- Dividend Yield
- GYRE N/A
- SBH N/A
- EPS Growth
- GYRE N/A
- SBH 4.93
- EPS
- GYRE 0.05
- SBH 1.66
- Revenue
- GYRE $105,757,000.00
- SBH $3,723,624,000.00
- Revenue This Year
- GYRE $51.85
- SBH $0.99
- Revenue Next Year
- GYRE $29.83
- SBH $1.52
- P/E Ratio
- GYRE $155.02
- SBH $5.49
- Revenue Growth
- GYRE N/A
- SBH 0.57
- 52 Week Low
- GYRE $7.00
- SBH $8.25
- 52 Week High
- GYRE $19.00
- SBH $14.79
- Technical
- Relative Strength Index (RSI)
- GYRE 33.88
- SBH 48.36
- Support Level
- GYRE $8.65
- SBH $8.56
- Resistance Level
- GYRE $9.50
- SBH $9.22
- Average True Range (ATR)
- GYRE 1.02
- SBH 0.37
- MACD
- GYRE -0.24
- SBH 0.06
- Stochastic Oscillator
- GYRE 12.81
- SBH 56.52
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.